AGEN Stock Analysis: Buy, Sell, or Hold?
AGEN - Agenus Inc.
$5.66
-0.46 (-7.52%)
▼
5d:
+61.71%
30d:
+66.96%
90d:
+36.39%
WAIT
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 10, 2026
26d
Get Alerted When AGEN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called AGEN this week
0% bullish • 1 bearish
0% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: AGEN is 45.5% above its trading range ($3.89). Market expects 0% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: AGEN is 45.5% above its trading range ($3.89). Market expects 0% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: AGEN is currently trading at $5.66, which is considered extended relative to its 30-day fair value range of $2.71 to $3.89. From a valuation perspective, the stock is trading at a discount (Forward PE: -34.0) compared to its historical average (5.1). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, AGEN is showing sideways momentum. Immediate support is located at $2.96, while resistance sits at $8.70. Short-term momentum is weak, with the stock down 7.5% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.50 (+153.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AGEN is showing sideways momentum. Immediate support is located at $2.96, while resistance sits at $8.70. Short-term momentum is weak, with the stock down 7.5% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.50 (+153.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.71 -
$3.89
Company Quality Score
40/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
36.7%
Protect Your Profits
AGEN is technically overbought (RSI 75). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+45.5% above its trading range)
- NEUTRAL: Mixed technical signals (45/100)
- BEARISH: Downward momentum (-7.5%)
- BULLISH: Trading 153.3% below Wall St target ($15.50)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Trading Range Analysis
30-Day Trading Range
$2.71 -
$3.89
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.96
Resistance Level
$8.70
Current Trend
Sideways
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-34.00
Wall Street Target
$15.50
(+153.3%)
Revenue Growth (YoY)
40.2%
Profit Margin
52.2%
PE vs Historical
-34.0 vs 5.1
CHEAP
Share & Embed Analysis
Last updated: July 14, 2026 11:43 AM ET
Data refreshes hourly during market hours. Next update: 12:43 PM
Data refreshes hourly during market hours. Next update: 12:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AGEN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 54 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$822 | 64 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 62 BUY |
Advanced AGEN Option Strategies
Professional options setups generated by AI based on today's AGEN price and gamma walls.
